Due to these constraints, clinicians often do not receive a full picture of a patient's hemodynamic state, which can result in misdiagnosis and incorrect treatment, leading to inefficient use of hospital resources, increased length of stay, and death [1 5].
Of many parameters to estimate utilization of resources, only length of stay (LOS) is systematically collected.
Due to these constraints, clinicians often do not receive a full picture of a patient's hemodynamic state, which can result in misdiagnosis and incorrect treatment, leading to inefficient use of hospital resources, increased length of stay, and death [ 1- 5].
Physician profiling is the practice whereby the practice pattern of a single physician or a group is expressed as some measure of the use of resources and/or length of stay during a defined period for the population served.
The cohorts were compared for the following measures of hospital resource utilization: length of stay, number of procedures, and mean total cost.
Logistic/linear regression models evaluated characteristics potentially associated with actual resource use (length of IV therapy, length of hospital stay [LOS], IV-to-oral antibiotic switch), and ES and ED (using literature-based and expert-verified criteria) outcomes.
We undertook analyses of an existing large dataset from a nationally representative survey to assess [ 1] the prevalence and factors associated with CDI among pneumonia and UTI and [ 2] the impact of CDI on in-hospital mortality and health resource utilization (length of stay [LOS] and total charges).
Given a number of ED resources, we can determine the necessary IU resources as the length of stay in the IU is varied.
Because housing is considered critical for sober living, inadequate housing resources impact lengths of stay: [Clients] know if they go back to their homeland there's all the drinking and drug use going on [so they] relocate, [but] sometimes we have people staying three weeks to a month later waiting for housing because of the [lack of] availability and the funding.
The additional resources spent on iv levetiracetam are partially offset by decreases in other costly healthcare resources such as length of ICU bed stay and laboratory monitoring.
